Active Ingredient: DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE
Proprietary Name: JULUCA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 50MG BASE;EQ 25MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N210192
Product Number: 001
Approval Date: Nov 21, 2017
Applicant Holder Full Name: VIIV HEALTHCARE CO
Marketing Status:
Prescription
Patent and Exclusivity Information